Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Clinical trial NCT00004176 · COMPLETED

Trial details

NCT number: NCT00004176
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Lung Cancer Radiation Toxicity

Start date: 1998-10-01
Primary completion: 2001-02-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.